Serial #79246706
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79246706 Trademark

Serial Number: 79246706 • Registration: 5980146

Serial #79246706 is a trademark filed by Chengdu Kanghong Pharmaceuticals Group Co., Ltd. on July 2, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Chengdu Kanghong Pharmaceuticals Group Co., Ltd. (7 trademarks)

No.36, Shuxi Rd.,
Sichuan , CN

Entity Type: 99

Trademark Details

Filing Date

July 2, 2018

Registration Date

February 11, 2020

Published for Opposition

November 26, 2019

Goods & Services

Royal jelly for pharmaceutical purposes; medicinal drinks; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Chemico pharmaceutical preparations for the treatment of hepatitis, dizziness, cardiovascular diseases, cerebrovascular diseases, depression, schizophrenia, insomnia, Alzheimer's disease, cholecystitis, gallstones, stomach diseases, digestive diseases, restlessness, laryngitis, pharyngitis, tonsillitis, tracheitis, pneumonia, influenza, cough, diabetes, nephropathy, eye diseases, tumor, vision loss and blindness in the elderly; Depuratives for the body; Medicines for human purposes, namely, Hypoglycemic drugs, Organotherapeutic drugs, Antitumor drugs, Antiepileptic drugs, Anti-cancer drugs, Antiviral drugs for treating influenza, Cytostatic drugs for medical purposes, Antipyretic drugs with sedative effect, Cardiovascular drugs used in myocardial infarction, Cardiovascular drugs used in treating arrhythmias, Cardiovascular drugs used in angina pectoris, Cardiovascular drugs for use in treating hypertension, Medicines for treating intestinal disorders, Non-prescription medicines, namely, pills, tablets, capsules, caplets for the treatment of hepatitis, dizziness, cardiovascular diseases, cerebrovascular diseases, depression, schizophrenia, insomnia, cholecystitis, gallstones, stomach diseases, digestive diseases, restlessness, laryngitis, pharyngitis, tonsillitis, tracheitis, pneumonia, influenza, cough, diabetes, nephropathy, eye diseases, tumor, cancer, vision loss and blindness in the elderly, Medicines for the treatment of gastrointestinal diseases, Medicines for alleviating constipation;pesticides; Biomedicines for the treatment of hepatitis, dizziness, cardiovascular diseases, cerebrovascular diseases, depression, schizophrenia, insomnia, cholecystitis, gallstones, stomach diseases, digestive diseases, restlessness, laryngitis, pharyngitis, tonsillitis, tracheitis, pneumonia, influenza, cough, diabetes, nephropathy, eye diseases, tumor, cancer, vision loss and blindness in the elderly; Medicines for veterinary purposes, namely, Anti-infective products for veterinary use, Bacterial preparations for medical and veterinary use, Veterinary vaccines; Transdermal patches for use in the treatment of circulating the blood, relaxing the muscles and joints, reducing swelling and pain, treating bruises, eliminating fatigue before and after sports; Nutritive substances for microorganism for medical purposes; disinfectants; tissues impregnated with antibacterial preparations; dental lacquer; medicinal tea; Chemical preparations for pharmaceutical purposes for the treatment of hepatitis, dizziness, cardiovascular diseases, cerebrovascular diseases, depression, schizophrenia, insomnia, cholecystitis, gallstones, stomach diseases, digestive diseases, restlessness, laryngitis, pharyngitis, tonsillitis, tracheitis, pneumonia, influenza, cough, diabetes, nephropathy, eye diseases, vision loss and blindness in the elderly; Capsules for medicines, namely, Allergy capsules, Decongestant capsules, Herbal male enhancement capsules, Ginseng capsules for medical purposes; Pharmaceutical preparations for the treatment of central nervous system diseases, fundus diseases, vascular diseases, diabetes, schizophrenia, depression, anxiety disorders, insomnia, hypertension, hyperlipidemia, dyspepsia, gastritis, abdominal pain, gallbladder diseases, laryngitis, pharyngitis, gingivitis, constipation, respiratory diseases, influenza, cough, bronchitis, asthma, Alzheimer's disease, cancer, tumor; medicinal alcohol; gases for medical purposes; Dietetic substances in the nature of beverages adapted for medical use; bath preparations, medicated; diagnostic agents for medical purposes; Raw material medicine for the treatment of hepatitis, dizziness, cardiovascular disease, cerebrovascular disease, depression, schizophrenia, insomnia, cholecystitis, gallstones, stomach problems, digestive diseases, irritability, laryngitis, pharyngitis, tonsillitis, bronchitis, pneumonia, Influenza, cough, diabetes, nephropathy, eye disease, cancer, vision loss and blindness in the elderly; pearl powder for medical purposes; Prepared Chinese medicine for the treatment of dizziness, palpitation, insomnia, irritability, nausea, paralysis, back pain, shoulder pain, hypertension, hyperlipidemia, acute stroke, hemiplegia, cerebral infarction, stroke, Alzheimer's disease, heart disease, influenza, diabetes, depression, cancer, tumor, fundus diseases; Bag filled with Chinese medicine for the treatment of dizziness, palpitations, insomnia, irritability, nausea, paralysis, back pain, shoulder pain, hypertension, hyperlipidemia, acute stroke, hemiplegia, cerebral infarction, stroke, Alzheimer's disease, heart disease, influenza, diabetes, depression, cancer, tumor, fundus disease

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 11, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jun 5, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 14, 2020 FINO
GENERIC MADRID TRANSACTION SENT TO IB
May 27, 2020 XXSS
GENERIC MADRID TRANSACTION CREATED
May 27, 2020 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 11, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 11, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 26, 2019 NPUB
PUBLISHED FOR OPPOSITION
Nov 26, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 6, 2019 NONP
ASSIGNED TO LIE
Oct 21, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 16, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 14, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 14, 2019 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 20, 2019 GNFN
FINAL REFUSAL E-MAILED
May 20, 2019 GNFR
FINAL REFUSAL WRITTEN
May 20, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 7, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 7, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 7, 2019 TROA
REFUSAL PROCESSED BY IB
Jan 5, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 16, 2018 RFCS
REFUSAL PROCESSED BY MPU
Dec 16, 2018 RFRR
APPLICATION FILING RECEIPT MAILED
Dec 7, 2018 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 5, 2018 RFCR
NON-FINAL ACTION WRITTEN
Dec 4, 2018 CNRT
ASSIGNED TO EXAMINER
Dec 3, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 3, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 29, 2018 REPR